Subcutaneous Abatacept in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: Results From a Phase III Open‐Label Study

OBJECTIVE: To investigate the pharmacokinetics, effectiveness, and safety of subcutaneous (SC) abatacept treatment over 24 months in patients with polyarticular‐course juvenile idiopathic arthritis (JIA). METHODS: In this phase III, open‐label, international, multicenter, single‐arm study, patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunner, Hermine I., Tzaribachev, Nikolay, Vega‐Cornejo, Gabriel, Louw, Ingrid, Berman, Alberto, Calvo Penadés, Inmaculada, Antón, Jordi, Ávila‐Zapata, Francisco, Cuttica, Rubén, Horneff, Gerd, Foeldvari, Ivan, Keltsev, Vladimir, Kingsbury, Daniel J., Viola, Diego Oscar, Joos, Rik, Lauwerys, Bernard, Paz Gastañaga, Maria Eliana, Rama, Maria Elena, Wouters, Carine, Bohnsack, John, Breedt, Johannes, Fischbach, Michel, Lutz, Thomas, Minden, Kirsten, Miraval, Tatiana, Ally, Mahmood M. T. M., Rubio‐Pérez, Nadina, Solau Gervais, Elisabeth, van Zyl, Riana, Li, Xiaohui, Nys, Marleen, Wong, Robert, Banerjee, Subhashis, Lovell, Daniel J., Martini, Alberto, Ruperto, Nicolino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Pediatric Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032847/
https://www.ncbi.nlm.nih.gov/pubmed/29481737
http://dx.doi.org/10.1002/art.40466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032847/
https://www.ncbi.nlm.nih.gov/pubmed/29481737
http://dx.doi.org/10.1002/art.40466

Ejemplares similares